PRME

Prime Medicine, Inc. Common Stock

Price

$3.54

return (12m)

9.26%

p/e

-2.88

p/bv

13.58

DIVIDEND YIELD

0.00%

PRME price

Prime Medicine, Inc. Common Stock

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PRME

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

13.46%

3 months

20.00%

1 year

9.26%

2 years

-18.99%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals PRME

Valuation

P/E

-2.88

Sector 7.79

Industry 7.79

P/BV

13.58

Sector 2.11

Industry 2.11

P/Revenue (PSR)

132.53

Sector 2.22

Industry 2.22

EV/EBITDA

-11.89

Sector -156.98

Industry -156.98

EV/EBIT

-11.39

Sector -1,355,776,171.42

Industry -1,355,776,171.42

P/EBITDA

-2.86

Sector 2.51

Industry 2.51

P/EBIT

-2.75

Sector 0.34

Industry 0.34

P/Total Assets

2.17

Sector 1.00

Industry 1.00

P/Net Current Assets

-4.81

Sector -3.84

Industry -3.84

P/Working Capital

8.30

Sector -5,077.26

Industry -5,077.26

EPS

-1.06

Sector 0.67

Industry 0.67

BVPS

0.22

Sector 10.17

Industry 10.17

Efficiency

Gross Margin

100.00%

Sector 32.61%

Industry 32.61%

EBITDA Margin

-3,608.70%

Sector -284.80%

Industry -284.80%

EBIT Margin

-3,764.35%

Sector -4.02%

Industry -4.02%

Operating Margin

-100.00%

Sector 4.45%

Industry 4.45%

Net Profit Margins

-100.00%

Sector 2.39%

Industry 2.39%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-471.97%

Sector 2.05%

Industry 2.05%

ROA

-75.45%

Sector -0.90%

Industry -0.90%

ROIC

-92.88%

Sector -118.95%

Industry -118.95%

Dividends

Dividend yield

0.00%

Sector 0.60%

Industry 0.60%

Payout

Sector 11.53%

Industry 11.53%

Debt

Current Ratio

3.05

Sector 1.44

Industry 1.44

Net Debt / EBITDA

1.14

Sector -39,522,158.34

Industry -39,522,158.34

Net Debt / EBIT

1.10

Sector -31.03

Industry -31.03

Net Debt / Equity

-1.19

Sector -0.72

Industry -0.72

Gross Debt / Equity

0.00

Sector 0.21

Industry 0.21

Equity/Assets

0.16

Sector 0.43

Industry 0.43

Liabilities/Assets

0.84

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

18.82%

Sector -

Industry -

Fundamentals PRME

DRAG THE FRAME TO SEE MORE DATA

PRME Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Prime Medicine, Inc. Common Stock

Prime Medicine, Inc. Common Stock

Average Investor10 user rating

4.0 (1 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Prime Medicine, Inc. Common Stock (United States) is listed on the Nasdaq and has a market capitalization of $540.74 million, with shareholders equity totaling $39.81 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Prime Medicine, Inc. Common Stock reported $4.08 million in revenue, generating net income of $-187.89 million.

Key financial metrics include a P/E ratio of -2.88, a price-to-book (P/B) ratio of 13.58, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PRME.

Market cap

$540.74 million

Net worth

$39.81 million

$39,810,000.00

Assets

$249.04 million

$249,040,000.00

Total Shares Outstanding

177.00 million

177,000,000

Average Daily Trading Volume

$3.41 million

$3,411,199.04

Sector

Others

Industry

Others

PRME

PRME revenue and profits

Financial Results PRME

DRAG THE FRAME TO SEE MORE DATA

PRME cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$388.61 33,84% (12M)

P/E

25.58

2.23%

ROE

13.33%

P/BV

3.41

SHEL - Shell PLC ADR

$92.77 34,82% (12M)

P/E

9.65

3.30%

ROE

14.29%

P/BV

1.38

STLA - Stellantis NV

$5.43 --44,42% (12M)

P/E

-0.61

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$317.10 5,40% (12M)

P/E

22.86

0.76%

ROE

81.04%

P/BV

18.52

SSNLF - Samsung Electronics Co Ltd

$- -0,00% (12M)

P/E

13.54

4.85%

ROE

1.69%

P/BV

0.23

ALIZY - Allianz SE ADR

$51.08 --13,60% (12M)

P/E

14.12

2.66%

ROE

17.89%

P/BV

2.53

TTE - TotalEnergies SE ADR

$90.07 54,62% (12M)

P/E

7.06

4.61%

ROE

21.42%

P/BV

1.51

NSRGY - Nestle SA ADR

$99.21 9,18% (12M)

P/E

11.98

4.01%

ROE

58.05%

P/BV

6.96